scorecardresearch
Add as a preferred source on Google
Sunday, March 1, 2026
TopicCovid drug

Topic: Covid drug

Free Covid precaution doses for 18-59 age group from July 15 at govt centres

As part of Centre’s Azadi Ka Amrit Mahotsav, this initiative will continue for 75 days.

WHO recommends two new Covid drugs, in discussions to secure ‘equitable access’

Extent to which Baricitinib & Sotrovimab will save lives depends on how available, affordable they will be, says WHO. New guidelines advise against use of Remdesivir, Ivermectin.

WHO approves Glaxo and Eli Lilly drugs to treat Covid amid Omicron surge

Eli Lilly’s rheumatoid arthritis drug and GlaxoSmithKline's monoclonal antibody won the WHO nod.

Antiviral Molnupiravir not in govt Covid protocol, but ‘millions of doses’ distributed in a week

Pharma companies say doctors working in community settings have begun pre-ordering the drug, several manufacturers gearing up to meet demand.

Scientists launch hunt to find naturally Covid-resistant people, 1,000 volunteers to be enrolled

The study looks for people genetically resistant to SARS-CoV-2 virus — if such natural immunity exists. Candidates are one of a couple, where only one partner fell sick, despite close contact.

No benefits of Doxycycline found in UK Covid patients, write Oxford researchers in Lancet study

According to researchers, the drug that has been commonly used to treat Covid respiratory symptoms does not reduce recovery time, hospital admissions, or deaths related to Covid.

Has Covid exposed limitations of ‘secretive’ ICMR? Some experts think so

The ICMR has increasingly drawn criticism from India's doctors and scientists, who have questioned its drug recommendations & lack of transparency on data related to variants.

Pharma firms and diagnostics developers need to unite. They are catalysts for saving lives

Studies of drugs like remdesivir and hydroxychloroquine were underpowered and small, and the results were conflicting and, in many cases, inconclusive.

Molnupiravir helps in faster recovery of mild Covid patients, says Hetero after phase 3 trials

Hyderabad-based pharma company, Hetero, announced promising interim results of phase 3 trials and has approached DCGI for emergency use authorisation for the drug in India.

Why Covid drug Ivermectin remains popular despite warnings & lack of evidence on efficacy

University of Oxford has launched a large study to investigate the use of Ivermectin for Covid-19 treatment, amid guidelines across the world, warning against the use of the drug. 

On Camera

Forget Kejriwal. Think of what our institutions are doing to enable authoritarianism

This decision is so damaging to the government that efforts will be made to ensure that it does not stand. The prosecution has said that it will file an appeal in the high court.

Crypto tumbles after US, Israel launch attacks on Iran

Bitcoin dropped as much as 3.8% to $63,038, while Ether, the second-largest token, slid 4.5% to $1,835. Roughly $128 billion in market value was erased across digital assets.

India has ordered more Polish drones, Indian firm keen to set up munitions factory in Poland—Warsaw’s envoy

New Delhi: India is right to pursue and strike terrorists where they are, as during Op Sindoor, Poland’s Ambassador to India Dr Piotr Antoni...

Pakistan is fighting a two-front war. I saw it coming 15 yrs ago

The Pakistani political leadership is weak and devoid of any intellect. Its diplomacy is entirely India-China-US focused and suffers from a presumptive view of Afghanistan as a vassal.